{"doi":"10.4103/picr.picr_190_21","title":"Role of investigational new drug committees in propelling the drug development ecosystem in India","abstract":null,"journal":"Perspectives in Clinical Research","year":2021,"id":612694,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1577696,"name":"Sanish Davis","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Role of investigational new drug committees in propelling the drug development ecosystem in India","abstract":null,"is_dataset_classified":null,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"34760642","pmcid":"PMC8525783","openalex_id":"https://openalex.org/W3201592945","authors":[],"funders":[],"total_grants":0,"fwci":0.1901,"citation_percentile":0.5761363,"influential_citations":0,"citation_trend":[{"year":2023,"count":1}],"oa_status":"gold","license":"cc-by-nc-sa","oa_locations":[{"url":"https://doi.org/10.4103/picr.picr_190_21","host_type":"journal"},{"url":"https://doi.org/10.4103/picr.picr_190_21","host_type":"publisher"},{"url":"https://journals.lww.com/10.4103/picr.picr_190_21","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/34760642","host_type":"repository"},{"url":"https://doaj.org/article/fd2ff32fe33845d3a7cdefaf28f3ee20","host_type":"repository"},{"url":"http://europepmc.org/pmc/articles/PMC8525783","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8525783","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC8525783","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC8525783?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Biotechnology and Related Fields","Pharmaceutical Economics and Policy"],"mesh_terms":[],"keywords":["Drug development","Drug","Investigational Drugs","Drug approval","Medicine","Drug discovery","Pharmacology","Business","Clinical trial","Bioinformatics","Biology","Internal medicine"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-02T04:35:35.554809Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}